I read a post somebody wanting to replace Nadar as CEO with Scott Kelley who is an orthopedic surgeon. That is a bad idea. If Nadar wanted to step down and maybe become Chairman of the board, I would want somebody maybe with a scientific background and a strong leader as CEO. Nadar maybe is not as polished as much as I would like but has done an awesome job getting us to where we are today. About today's new; it is not that bad, its merely the FDA saying get us more info. No biggie. No new trials needed that is huge..Great buying opportunity.